1 |
exp Prostatic Neoplasms/ (290920) |
2 |
Prostate/ (74575) |
3 |
exp Neoplasms/ (6500732) |
4 |
2 and 3 (38049) |
5 |
(prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087) |
6 |
Prostatectomy/ (69779) |
7 |
prostatectom*.tw. (63158) |
8 |
or/1,4–7 (373736) |
9 |
Genetic Testing/ (60447) |
10 |
((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791) |
11 |
exp Gene Expression Profiling/ (171739) |
12 |
((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757) |
13 |
((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822) |
14 |
or/9–13 (429710) |
15 |
8 and 14 (6949) |
16 |
prolaris*.tw. (31) |
17 |
or/15–16 (6958) |
18 |
economics/ (251267) |
19 |
economics, medical/ or economics, pharmaceutical/ or exp economics, hospital/ or economics, nursing/ or economics, dental/ (735077) |
20 |
economics.fs. (381957) |
21 |
(econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871) |
22 |
exp “costs and cost analysis”/ (510897) |
23 |
cost*.ti. (234727) |
24 |
cost effective*.tw. (250095) |
25 |
(cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523) |
26 |
models, economic/ (134522) |
27 |
markov chains/ or monte carlo method/ (119887) |
28 |
(decision adj1 (tree* or analy* or model*)).tw. (33792) |
29 |
(markov or markow or monte carlo).tw. (99281) |
30 |
quality-adjusted life years/ (26577) |
31 |
(QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975) |
32 |
((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325) |
33 |
or/18–32 (2279891) |
34 |
17 and 33 (242) |
35 |
34 use pmoz,cctr,coch,dare,clhta (57) |
36 |
17 use cleed (1) |
37 |
or/35–36 (58) |
38 |
limit 37 to english language [Limit not valid in CDSR,DARE; records were retained] (56) |
39 |
limit 38 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (37) |
40 |
exp prostate tumor/ (181348) |
41 |
prostate/ (74575) |
42 |
exp neoplasm/ (6495582) |
43 |
and/41–42 (38033) |
44 |
(prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087) |
45 |
prostatectomy/ (69779) |
46 |
prostatectom*.tw. (63158) |
47 |
or/40,43–46 (359573) |
48 |
genetic screening/ (88435) |
49 |
((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791) |
50 |
gene expression profiling/ (171701) |
51 |
((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757) |
52 |
((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822) |
53 |
or/48–52 (445179) |
54 |
47 and 53 (6881) |
55 |
prolaris*.tw. (31) |
56 |
or/54–55 (6889) |
57 |
Economics/ (251267) |
58 |
Health Economics/ or exp Pharmacoeconomics/ (214674) |
59 |
Economic Aspect/ or exp Economic Evaluation/ (394850) |
60 |
(econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871) |
61 |
exp “Cost”/ (510897) |
62 |
cost*.ti. (234727) |
63 |
cost effective*.tw. (250095) |
64 |
(cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523) |
65 |
Monte Carlo Method/ (50881) |
66 |
(decision adj1 (tree* or analy* or model*)).tw. (33792) |
67 |
(markov or markow or monte carlo).tw. (99281) |
68 |
Quality-Adjusted Life Years/ (26577) |
69 |
(QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975) |
70 |
((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325) |
71 |
or/57–70 (1871276) |
72 |
56 and 71 (183) |
73 |
limit 72 to english language [Limit not valid in CDSR,DARE; records were retained] (175) |
74 |
limit 73 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (124) |
75 |
74 use emez (89) |
76 |
39 or 75 (126) |
77 |
76 use pmoz (26) |
78 |
76 use emez (89) |
79 |
76 use coch (8) |
80 |
76 use cctr (1) |
81 |
76 use clhta (1) |
82 |
76 use cleed (1) |
83 |
76 use dare (0) |
84 |
remove duplicates from 76 (104) |